Back to Search
SVETISLAVA VUKELJA, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1851335442Individual
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
J9840(TX)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
J9840(TX)
Research & Publications (20)
Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions.
PMID 17264760·Anticancer Drugs·2007
3-trial
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
PMID 19139988·Breast Cancer Res Treat·2009
8-other
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
PMID 19036692·Clin Colorectal Cancer·2008
3-trial
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.
PMID 18236006·Invest New Drugs·2008
3-trial
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.
PMID 17947724·J Clin Oncol·2007
4-observational
Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
PMID 17386123·Clin Breast Cancer·2007
3-trial
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
PMID 17329190·Lancet Oncol·2007
8-other
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
PMID 17135639·J Clin Oncol·2006
3-trial
Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy.
PMID 16982458·Cancer Invest·2006
3-trial
Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
PMID 16966367·Ann Oncol·2006
3-trial
Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer.
PMID 16581300·Mol Ther·2006
3-trial
Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors.
PMID 16278405·Clin Cancer Res·2005
3-trial
Results of a phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer.
PMID 15929806·Clin Colorectal Cancer·2005
3-trial
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
PMID 15748464·Clin Breast Cancer·2005
3-trial
Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
PMID 15585416·Mol Ther·2005
3-trial
Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase III trial.
PMID 15507172·Clin Breast Cancer·2004
3-trial
Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients.
PMID 15493356·Cancer Invest·2004
3-trial
Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
PMID 15245619·Clin Breast Cancer·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 910 EAST HOUSTON STREET
TYLER, TX 75702 - Phone
- (903) 579-9800
Quick Facts
- NPI
- 1851335442
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile